{
  "id": "75ed3137-7d31-44fe-8a1c-7d50a98ad13d",
  "answer": "Atrium Therapeutics, Inc. Common Stock has a balanced company news read. Its latest completed weekly trend is negative.",
  "status": "balanced",
  "as_of": "2026-08-18T03:29:53.212039+00:00",
  "period_end": "2026-08-14",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "NASDAQ:RNA",
    "name": "Atrium Therapeutics, Inc. Common Stock (RNA)",
    "identity": {
      "sharemaestro_id": "52e0e6c4-6cfc-4cd8-99c9-2c55744073a1",
      "canonical_name": "Atrium Therapeutics, Inc. Common Stock",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "RNA"
      ],
      "provider_symbols": {
        "eodhd": [
          "RNA.US"
        ],
        "yahoo": "RNA",
        "market": "NASDAQ",
        "alpha_vantage": "RNA"
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "United States",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 51.0,
  "confidence": 18,
  "evidence_count": 31,
  "independent_sources": 4,
  "freshest_evidence": "2026-08-14T21:11:43+00:00",
  "previous_read": 51.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "RNA",
    "company": "Atrium Therapeutics, Inc. Common Stock",
    "country": "United States",
    "currency": "USD",
    "exchange": "NASDAQ",
    "industry": "Biotechnology",
    "week_end": "2026-08-14",
    "asset_type": "equity",
    "news_count": 31,
    "trend_state": "negative",
    "latest_close": "12.840000",
    "score_change": 0.0,
    "weekly_change": 4.052,
    "evidence_status": "provisional",
    "sentiment_score": 51
  },
  "canonical_url": "https://sharemaestro.com/evidence/75ed3137-7d31-44fe-8a1c-7d50a98ad13d/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/52e0e6c4-6cfc-4cd8-99c9-2c55744073a1/"
    },
    {
      "label": "Technicals & Market Dynamics",
      "url": "https://sharemaestro.com/terminal/52e0e6c4-6cfc-4cd8-99c9-2c55744073a1/technicals/"
    },
    {
      "label": "Technical Research Pack",
      "url": "https://sharemaestro.com/terminal/52e0e6c4-6cfc-4cd8-99c9-2c55744073a1/technical-pack/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/52e0e6c4-6cfc-4cd8-99c9-2c55744073a1/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=RNA"
    }
  ],
  "related_research": {
    "type": "price_technicals_and_market_dynamics",
    "name": "Technicals & Market Dynamics",
    "publisher": "Sharemaestro",
    "framework": "Market Dynamics",
    "methodology": "proprietary",
    "scope": "completed-week price structure and underlying market support",
    "period_end": "2026-08-14",
    "url": "https://sharemaestro.com/terminal/52e0e6c4-6cfc-4cd8-99c9-2c55744073a1/technicals/",
    "technical_pack_url": "https://sharemaestro.com/terminal/52e0e6c4-6cfc-4cd8-99c9-2c55744073a1/technical-pack/",
    "technical_pack_pdf_url": "https://sharemaestro.com/terminal/52e0e6c4-6cfc-4cd8-99c9-2c55744073a1/technical-pack/download.pdf",
    "technical_pack_data_url": "https://sharemaestro.com/terminal/52e0e6c4-6cfc-4cd8-99c9-2c55744073a1/technical-pack/data.json",
    "description": "Sharemaestro's proprietary completed-week analysis of whether underlying market support is strengthening or weakening beneath price. It complements this company-news record and is not an input to the news score.",
    "relationship": "complementary_research",
    "included_in_news_score": false
  },
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "366493fd20200a9a31a9f0cb70a6f67f03154af47d705febb429fa10db9b082f",
  "citation": "Sharemaestro, Atrium Therapeutics, Inc. Common Stock (RNA), 2026-08-18, https://sharemaestro.com/evidence/75ed3137-7d31-44fe-8a1c-7d50a98ad13d/"
}